Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical subgroupL04AH
- Chemical substanceL04AH01Sirolimus
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 8 registrations
- Rapamune1 MG · Tablet · Pfizer Canada Ulc
- Rapamune1 MG / ML · Solution · Pfizer Canada Ulc
- GD-Sirolimus1 MG / ML · Solution · Genmed A Division of Pfizer Canada Ulc
- GD-Sirolimus1 MG · Tablet · Genmed A Division of Pfizer Canada Ulc
United States
FDA · 6 registrations
- Fyarro100MG/VIAL · powder · Aadi
- Rapamune1MG/ML · solution · PF Prism CV
- Rapamune0.5MG, 1MG, 2MG … · tablet · PF Prism CV
- Sirolimus1MG/ML · solution · Apotex
At a glance
- ATC code
- L04AH01
- Registers
- 9
- Historical lists
- 2
- Registrations
- 41
- With their own page
- 31
- Companies
- 16
All medicines with Sirolimus
Human medicines from every register that match Sirolimus by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
41 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Sirolimus | United States | 1MG/ML | solution | Marketed | Apotex |
| Sirolimus | United States | 0.5MG, 1MG, 2MG | tablet | Marketed | Alkem Labs LTD |
| GD-Sirolimus | Canada | 1 MG / ML | Solution | Authorised | Genmed A Division of Pfizer Canada Ulc |
| GD-Sirolimus | Canada | 1 MG | Tablet | Authorised | Genmed A Division of Pfizer Canada Ulc |
| Fyarro | United States | 100MG/VIAL | powder | Marketed | Aadi |
| Rapamune | United States | 1MG/ML | solution | Marketed | PF Prism CV |
| Rapamune | United States | 0.5MG, 1MG, 2MG … | tablet | Marketed | PF Prism CV |
| Hyftor | United States | 0.2% | gel | Marketed | Nobelpharma |
| RAPAMUNE 1 mg/ml SOLUCION ORAL | Spain | 1 mg | solución oral | Marketed | Pfizer Europe Ma Eeig |
| Hyftor | European Union | Authorised | Plusultra pharma GmbH | ||
| Rapamune | European Union | Authorised | Pfizer Europe MA EEIG | ||
| RAPAMUNE 0,5 mg COMPRIMIDOS RECUBIERTOS | Spain | 0,5 mg | comprimido recubierto | Marketed | Pfizer Europe Ma Eeig |
| RAPAMUNE 1 mg COMPRIMIDOS RECUBIERTOS | Spain | 1 mg | comprimido recubierto | Marketed | Pfizer Europe Ma Eeig |
| RAPAMUNE 2 mg COMPRIMIDOS RECUBIERTOS | Spain | 2 mg | comprimido recubierto | Marketed | Pfizer Europe Ma Eeig |
| Hyftor 2 mg/g gel | Netherlands | Gel | Authorised | Plusultra Pharma GmbH | |
| Rapamune 0,5 mg omhulde tabletten | Netherlands | Omhulde tablet | Authorised | Pfizer Europe MA EEIG | |
| Rapamune 1 mg/ml drank | Netherlands | Drank | Authorised | Pfizer Europe MA EEIG | |
| Rapamune 1 mg omhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Pfizer Europe MA EEIG | |
| RAPAMUNE 2 mg COMPRIMIDOS RECUBIERTOS | Spain | 2 mg | comprimido recubierto | Authorised | Pfizer Europe Ma Eeig |
| Rapamune 2 mg omhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Pfizer Europe MA EEIG | |
| Rapamune | Canada | 1 MG / ML | Solution | Marketed | Pfizer Canada Ulc |
| Rapamune | Canada | 1 MG | Tablet | Marketed | Pfizer Canada Ulc |
| Rapamune® | Serbia | 1mg | obložena tableta | Authorised | Pfizer SRB D.O.O. |
| Rapamune® | Serbia | 1mg | obložena tableta | Authorised | Pfizer SRB D.O.O. |
| RAPAMUNE TABLET 0.5 mg | Singapore | 0.5 mg | tablet, sugar coated | Authorised | Pfizer Private Limited |